Antitumor antisense sequences directed against R1 and R2 components of ribonucleotide reductase
US7405205B2 · kind B2 · utility
1Cited by
9References
73Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 29, 2003 |
| Grant date | Jul 29, 2008 |
| Priority date | — |
| Expiry date | Jan 25, 2025 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2799/027
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Compounds and methods for modulating cell proliferation, preferably inhibiting the proliferation of tumor cells are described. Compounds that may be used to modulate cell proliferation include antisense oligonucleotides complementary to regions of the mammalian ribonucleotide reductase genes.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.